Table 1.
Clinical outcomes | Total (n = 245) | White British (n = 93) (38.0%) | Black African (n = 85) (34.7%) | Black Caribbean (n = 67) (27.3%) | Test statistics | df | p value |
---|---|---|---|---|---|---|---|
Duration of baseline episode (weeks) | |||||||
Median (IQR) | 8 (6–20) | 8 (4–20) | 8 (4–16) | 8 (8–20) | 2.77a | 2 | 0.25 |
Symptomatic remission, ever | |||||||
n (%) | 149 (63.1) | 53 (60.9) | 55 (64.7) | 41 (64.1) | 0.30b | 2 | 0.86 |
Symptomatic recovered, ever | |||||||
n (%) | 63 (28.4) | 25 (31.3) | 21 (25.3) | 17 (28.8) | 0.64b | 2 | 0.73 |
GAF symptoms change | |||||||
Mean (sd) | 13.3 (26.8) | 14.9 (27.1) | 12.1 (25.1) | 11.8 (30.6) | 0.14c | 95 | 0.87 |
GAF disability change | |||||||
Mean (sd) | 9.4 (23.9) | 8.6 (25.6) | 6.7 (21.9) | 16.8 (23.6) | 1.12c | 96 | 0.33 |
w weeks, sd standard deviation, df degrees of freedom, GAF global assessment of functioning
aRank test χ 2 for the count data
b χ 2 tests for categorical variables
cANOVA test for continuous variables